Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelam Varma

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|November 16, 2021
PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of <i>BCR-ABL1</i>-like acute lymphoblastic leukaemia in Indian patientsDikshat Gopal Gupta, Neelam Varma, Ashish Kumar, et al.
Blood Research|August 17, 2021
Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experienceGaurav Prakash, Arihant Jain, Kamalkant Sahu, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 2, 2019
Clinicopathological Profile of Myelomatous Pleural Effusion: Single-center Real-world Experience and Review of LiteratureUday Yanamandra, Prateek Deo, Kamal Kant Sahu, et al.
British Journal of Haematology|December 18, 2022
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre studyCharanpreet Singh, Uday Yanamandra, Parathan Karunakaran, et al.
Leukemia Research|September 29, 2023
Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acidCharanpreet Singh, Parathan Karunakaran, Uday Yanamandra, et al.
Cancer|July 27, 2023
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from IndiaDikshat Gopal Gupta, Neelam Varma, Praveen Sharma, et al.
Pediatric Blood & Cancer|March 21, 2020
Autologous stem cell transplant for high-risk neuroblastoma: Achieving cure with low-cost adaptationsRicha Jain, Rekha Hans, Sidharth Totadri, et al.
Hemasphere|October 7, 2022
Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe ProtocolSanjeev Kumar Gupta, Minu Singh, Pragna H Chandrashekar, et al.
The Journal of Molecular Diagnostics : JMD|July 20, 2023
A Well-Curated Cost-Effective Next-Generation Sequencing Panel Identifies a Diverse Landscape of Pathogenic and Novel Germline Variants in a Bone Marrow Failure Cohort in a Resource-Constraint SettingSwetha Pallavelangini, Gnanamani Senguttuvan, Prateek Bhatia, et al.
Leukemia & Lymphoma|June 14, 2022
Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory studyKripa Shanker Kasudhan, Amol N Patil, Aditya Jandial, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|November 16, 2021
PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of <i>BCR-ABL1</i>-like acute lymphoblastic leukaemia in Indian patientsDikshat Gopal Gupta, Neelam Varma, Ashish Kumar, et al.
Blood Research|August 17, 2021
Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experienceGaurav Prakash, Arihant Jain, Kamalkant Sahu, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 2, 2019
Clinicopathological Profile of Myelomatous Pleural Effusion: Single-center Real-world Experience and Review of LiteratureUday Yanamandra, Prateek Deo, Kamal Kant Sahu, et al.
British Journal of Haematology|December 18, 2022
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre studyCharanpreet Singh, Uday Yanamandra, Parathan Karunakaran, et al.
Leukemia Research|September 29, 2023
Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acidCharanpreet Singh, Parathan Karunakaran, Uday Yanamandra, et al.
Cancer|July 27, 2023
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from IndiaDikshat Gopal Gupta, Neelam Varma, Praveen Sharma, et al.
Pediatric Blood & Cancer|March 21, 2020
Autologous stem cell transplant for high-risk neuroblastoma: Achieving cure with low-cost adaptationsRicha Jain, Rekha Hans, Sidharth Totadri, et al.
Hemasphere|October 7, 2022
Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe ProtocolSanjeev Kumar Gupta, Minu Singh, Pragna H Chandrashekar, et al.
The Journal of Molecular Diagnostics : JMD|July 20, 2023
A Well-Curated Cost-Effective Next-Generation Sequencing Panel Identifies a Diverse Landscape of Pathogenic and Novel Germline Variants in a Bone Marrow Failure Cohort in a Resource-Constraint SettingSwetha Pallavelangini, Gnanamani Senguttuvan, Prateek Bhatia, et al.
Leukemia & Lymphoma|June 14, 2022
Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory studyKripa Shanker Kasudhan, Amol N Patil, Aditya Jandial, et al.
Pageof 26